Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 5—May 2004
Research

Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages

Robin A. Howe*, Alastair Monk†, Mandy Wootton*, Timothy R. Walsh‡, and Mark C. Enright†Comments to Author 
Author affiliations: *Southmead Hospital, Bristol, United Kingdom; †University of Bath, Bath, United Kingdom; ‡University of Bristol, Bristol, United Kingdom

Main Article

Table

Characteristics of study isolates with reduced vancomycin susceptibilitya

Genotype
Clonal type agr type Vancomycin resistance phenotype
(no. of strains) PAP-AUC Country of origin Antimicrobial susceptibility*†
CC ST SCCmec Lzd Syn Gen Cip Rif
5
5
I
EMRSA-3
II
hVISA (1)
0.98
UK
S
S
R
R
R
I
VISA (1)
1.9
USA
S
S
R
R
S
5
5
II
New York/Japanese
II
hVISA (10)
0.97–1.23
Japan, Sweden, France, Poland, UK, USA, Norway
S
S
S/R
S/R
S/R
I or II
VISA (3)
1.4–1.92
USA
S
S
S
R
S/R
5
5
IV
Pediatric
I or II
hVISA (3)
1.19–1.32
UK
S
S
S
S/R
S/R
5
5
NT

I
VISA (1)
1.44
France
S
S
R
R
R
8
8
I

II
hVISA (3)
0.92–1.32
France, UK, Norway
S
S
R
R
R
8
8
II
Irish-1
II
hVISA (3)
1.04–1.2
France, USA, Norway
S
S
S/R
R
S/R
8
8
IV
EMRSA-4, -6
I
hVISA(11)
0.94–1.24
France, USA
S
S/R
S/R
R
S/R
22
22
IV
EMRSA-15
I or II
hVISA (7)
0.9–1.25
UK
S
S
S
R
S/R
25
25
NT

I
hVISA(1)
1.13
UK
S
S
R
R
R
30
36
II
EMRSA-16
II
hVISA (3)
0.92–1.17
UK
S
S
R
R
R
45
45
II

I
hVISA (1)
1
USA
S
S
R
R
S
8
239
I or II
Brazilian/Portuguese
I or II
hVISA (10)
0.9–1.22
France, Poland, China, Norway, UK
S
S
R
S/R
S/R
I
VISA (3)
1.44–3.01
France, Poland, UK
S
S/R
R
R
S/R
8
239
NT

I
hVISA (1)
0.92
France
S
S
R
R
R
8
246
NT

I
hVISA (1)
1.13
Norway
S
S
R
R
R
8 247 I Iberian I
VISA (1)
1.57
UK
S
S
R
R
R
I or II hVISA (37) 0.9–1.33 France, Poland, UK, Norway S S R R S/R

aS, susceptible; R, resistant; NT, nontypeable; PAP-AUC, population analysis profiling followed by measuring the area under the curve; Lzd, linezolid; Syn, synercid; Gen, gentamicin; Cip, ciprofloxacin; Rif, rifampin; CC, clonal complex; ST, sequence type; EMRSA, methicillin-resistant Staphylococcus aureas found in the United Kingdom (UK) ; hVISA, heterogeneous vancomycin-intermediate S. aureus; USA, United States of America.

Main Article

Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external